The heatmap showed that Nature-killer cell gene expression was correlated with WHO grade, IDH1 mutation, MGMT promoter methylation, 1p19q co-deletion, tumor subtype in glioma patients in CGGA (Fig. 2A) and TCGA datasets (Fig. 2B). This evidence concerns the gene IDH1 and central nervous system cancer.